JP2018090608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018090608A5 JP2018090608A5 JP2018024038A JP2018024038A JP2018090608A5 JP 2018090608 A5 JP2018090608 A5 JP 2018090608A5 JP 2018024038 A JP2018024038 A JP 2018024038A JP 2018024038 A JP2018024038 A JP 2018024038A JP 2018090608 A5 JP2018090608 A5 JP 2018090608A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- gene recombinant
- claudin
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004965 antibodies Human genes 0.000 claims 5
- 108090001123 antibodies Proteins 0.000 claims 5
- 102000005614 monoclonal antibodies Human genes 0.000 claims 3
- 108010045030 monoclonal antibodies Proteins 0.000 claims 3
- 241000700159 Rattus Species 0.000 claims 2
- 210000004408 Hybridomas Anatomy 0.000 claims 1
- 108091006028 chimera Proteins 0.000 claims 1
Claims (4)
- ＶＨの配列が配列番号５、ＶＬの配列が配列番号６であるラット抗クラウディン４モノクローナル抗体。
- モノクローナル抗体が、遺伝子組換え抗体である請求項１に記載の抗体。
- 前記遺伝子組換え抗体が、ヒトIgG骨格を有するキメラ抗体である請求項２に記載の遺伝子組換え抗体。
- 請求項１に記載のラット抗クラウディン４モノクローナル抗体を産生するハイブリドーマ。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013040211 | 2013-03-01 | ||
| JP2013040211 | 2013-03-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014036111A Division JP2014193853A (ja) | 2013-03-01 | 2014-02-27 | 抗体、フラグメント、医薬組成物、分子及び腫瘍マーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018090608A JP2018090608A (ja) | 2018-06-14 |
| JP2018090608A5 true JP2018090608A5 (ja) | 2018-11-08 |
| JP6484785B2 JP6484785B2 (ja) | 2019-03-20 |
Family
ID=51427923
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014036111A Pending JP2014193853A (ja) | 2013-03-01 | 2014-02-27 | 抗体、フラグメント、医薬組成物、分子及び腫瘍マーカー |
| JP2018024038A Active JP6484785B2 (ja) | 2013-03-01 | 2018-02-14 | 抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014036111A Pending JP2014193853A (ja) | 2013-03-01 | 2014-02-27 | 抗体、フラグメント、医薬組成物、分子及び腫瘍マーカー |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JP2014193853A (ja) |
| WO (1) | WO2014132647A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018123949A1 (ja) | 2016-12-28 | 2018-07-05 | 国立医薬品食品衛生研究所長が代表する日本国 | 抗クローディン－２モノクローナル抗体 |
| CN112368300A (zh) * | 2018-04-06 | 2021-02-12 | 帝人制药株式会社 | Spns2中和抗体 |
| WO2020071489A1 (ja) * | 2018-10-04 | 2020-04-09 | 国立大学法人大阪大学 | 尿路上皮がんを検査する方法 |
| CN117551194A (zh) | 2020-03-19 | 2024-02-13 | 基因泰克公司 | 同种型选择性抗TGF-β抗体及使用方法 |
| TW202309083A (zh) * | 2021-04-22 | 2023-03-01 | 日商安斯泰來製藥股份有限公司 | 抗ｃｌｄｎ４－抗ｃｄ１３７雙特異性抗體 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008114733A1 (ja) * | 2007-03-16 | 2008-09-25 | Kyowa Hakko Kirin Co., Ltd. | 抗Claudin-4抗体 |
| US9274119B2 (en) * | 2008-01-11 | 2016-03-01 | The University Of Tokyo | Anti-CLDN6 antibody |
-
2014
- 2014-02-27 JP JP2014036111A patent/JP2014193853A/ja active Pending
- 2014-02-27 WO PCT/JP2014/001039 patent/WO2014132647A1/ja active Application Filing
-
2018
- 2018-02-14 JP JP2018024038A patent/JP6484785B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018090608A5 (ja) | ||
| EA201991577A1 (ru) | Новые антитела против рецептора трансферрина человека, способные преодолевать гематоэнцефалический барьер | |
| WO2016207304A8 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2017114866A5 (ja) | ||
| HRP20192280T1 (hr) | Anti-ceacam6 protutijela i njihova uporaba | |
| JP2020504101A5 (ja) | ||
| JP2016185981A5 (ja) | ||
| JP2012501669A5 (ja) | ||
| JP2017176174A5 (ja) | ||
| RU2017128882A (ru) | Антитела к биотину и способы их применения | |
| ES2776179T3 (es) | Anticuerpos dirigidos contra determinantes de la superficie de S. aureus | |
| WO2016023019A3 (en) | Anti-trem2 antibodies and methods of use thereof | |
| PE20181363A1 (es) | Variantes optimizadas de anticuerpos anti-vegf | |
| WO2017075432A3 (en) | Anti-siglec-9 antibodies and methods of use thereof | |
| PE20181336A1 (es) | Anticuerpos que se unen a interleucina 8 (il-8) y sus usos | |
| JP2017534262A5 (ja) | ||
| JP2012501670A5 (ja) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| MX2017005987A (es) | Anticuerpos anti-interleucina(il)-1beta y metodos de uso. | |
| JP2011157378A5 (ja) | ||
| NZ630610A (en) | Tau peptides, anti-tau antibodies, and methods of use thereof | |
| HRP20210120T1 (hr) | Protutijela protiv tnf alfa i njihovi funkcionalni fragmenti | |
| HRP20210123T1 (hr) | Protutijela protiv tnf alfa i njihovi funkcionalni fragmenti | |
| RU2016107814A (ru) | Новое антитело к tslp-рецептору человека | |
| HRP20220069T1 (hr) | Antitijelo |